Company Profile

Novo Nordisk A/S

Novo Allé

Bagsvaerd 2880 Denmark
Phone: 45-4444-8888 Fax: 45-4449-0555

Industry
Big Pharma

Segment
Medical Device - Diabetes/Obesity
Research and Development

Collaborations
CelTor Biosystems, Inc. Research collaboration
Aradigm Corporation Commercial agreement to develop AERx technology for the delivery of insulin, insulin analogues and other glucose-lowering agents for diabetes management.
Incyte Corporation
Maxygen, Inc.
Intergen Company

Company News

Sandoz, Inc. Stays In New Jersey, Moves To Former Home Of Novo Nordisk A/S (NVO) 7/10/2014 7:49:47 AM

FDA Approves Novo Nordisk A/S (NVO)'s NovoSeven® RT To Treat Glanzmann's Thrombasthenia (GT) With Refractoriness 7/7/2014 12:23:56 PM

Novo Nordisk A/S (NVO): Share Repurchase Programme 7/7/2014 7:58:34 AM

Novo Nordisk A/S (NVO) - Share Repurchase Programme 7/1/2014 8:49:29 AM

Novo Nordisk A/S (NVO) Will Double Revenue Within A Decade: Deputy CEO 6/25/2014 8:35:04 AM

Novo Nordisk A/S (NVO) And NBA Legend Dominique Wilkins Spotlight Full-Court Approach To Type 2 Diabetes Management 6/25/2014 7:44:40 AM

Novo Nordisk A/S (NVO) - Share Repurchase Programme 6/23/2014 7:28:01 AM

Positive New Phase 3a Data On Novo Nordisk A/S (NVO)'s Liraglutide 6/23/2014 6:13:55 AM

Novo Nordisk A/S (NVO) - Share Repurchase Programme 6/17/2014 9:12:00 AM

//-->